1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CE5E57CBB129C74385256BA400537641
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/brief-case-studies-in-professional-and-patient-advocacy-relations?opendocument
18
19opendocument
20100.26.182.28
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Patient Advocacy

Brief Case Studies in Professional and Patient Advocacy Relations

DB Image

ID: 4265


Features:


Words: 2,562


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Learning by someone else’s mistakes and successes can save both time and money. Case studies assist companies in determining how to position their own market plans. Companies can use this information to recognize some of the pitfalls and successes in the realm of Professional and Advocacy Relations. This nine-page document covers eight case studies in the pharmaceutical industry.

Key topics include:
-- Overseas Advocacy: BMS' work with AIDS advocacy groups
-- Creating a Market: Pfizer’s work with advocacy groups during the launch of Viagra.
-- Crafting Cross-Therapeutic Activities: Janssen Pharmaceutica's ElderCare division and work surrounding products such as anti-psychotic Risperdal, pain reliever Duragesic and proton pump Aciphex.

The case studies draw on public domain documents and secondary research sources.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device


Companies Profiled:
Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; Merck; GlaxoSmithKline; Novartis; Pfizer; Roche

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.